ALHC vs NBIX · P/E 154, rev $2.57B vs P/E 45, rev $1.77B
Alignment Healthcare LLC (ALHC) versus Neurocrine Biosciences Inc (NBIX) — a side-by-side from cached financials, not a winner call.
Alignment Healthcare LLC (ALHC) is a healthcare plans company listed on US.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
Latest reported ALHC revenue for 2026-06-30 was $2.57B. Net income was $48.0M. ALHC currently screens at market cap $3.18B and trailing P/E 153.7.
Latest reported NBIX revenue for 2026-06-30 was $1.77B. Net income was $342.3M. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
ALHC currently screens at market cap $3.18B and trailing P/E 153.7. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Not investment advice. Open the ALHC and NBIX stock pages for the full models.
Not investment advice.